Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04312022 · ClinicalTrials.gov registry record · NA
Impacts of a Combined Berry Extract Supplement on Vascular Function and Oxygen Utility Capacity in Young Adults
A NA study, sponsored by University of Nebraska.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT04312022 is a NA study that has completed, run by University of Nebraska. The registered enrollment target is 18 participants.
The verdict
NCT04312022, a NA study, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the impacts of a combined berry extract supplement (hawthorn berry, tart cherry, and bromelain extracts) on total antioxidant capacity, endothelial function, blood pressure, oxygen utility capacity, and fatigue index in healthy young adults.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Berry extract
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2018-11-04 |
| Est. Completion | 2019-06-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04312022
The ClinicalTrials.gov registry entry for NCT04312022 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04312022 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04312022 about?
NCT04312022 is a clinical study titled "Impacts of a Combined Berry Extract Supplement on Vascular Function and Oxygen Utility Capacity in Young Adults". The purpose of this study is to investigate the impacts of a combined berry extract supplement (hawthorn berry, tart cherry, and bromelain extracts) on total antioxidant capacity, endothelial function, blood pressure, oxygen utility capacity, and fatigue index in healthy young adults.
What is the current status of trial NCT04312022?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2018-11-04. Estimated completion is 2019-06-13.
What interventions are being tested in trial NCT04312022?
The interventions under investigation include: Placebo (OTHER), Berry extract (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04312022?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.